)
)
Biosyent Investor Relations Material
Latest events
Q2 2024
Biosyent
Access the full event backlog
Slides, Transcripts, and Reports from 11,000+ public companies
Latest reports from Biosyent Inc
Access all reports
BioSyent Inc., a specialty pharmaceutical company, sources, acquires or in-licenses, develops, and sells pharmaceutical and other healthcare products in Canada. It focuses on the acquisition of oncology drugs, medical devices and other healthcare products. BioSyent Inc. is based in Mississauga, Canada.
Key slides for Biosyent Inc
Q2 2024
Biosyent Inc
Q1 2024
Biosyent Inc
Latest articles
)
Deere & Company: Shaping the Future of Agriculture Since 1837
Detailing the history of agriculture and Deere & Company, all the way from 1837 to the present day.
25 Oct 2024
)
Intel: Semiconductors & Strategic Inflection Points
Founded in 1968, Intel has been a key player in the American semiconductor industry, with its processors powering computers worldwide.
15 Oct 2024
)
Our Favorite Spin-off Stories Since 2000
Spin-off motives vary widely across different companies, but the underlying objective remains the same: enhancing long-term shareholder value.
17 Oct 2024
Ticker symbol
RX
Country
🇨🇦 Canada